Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Fraunhofer ITMP is a temporary project partner for the additional research project focussing on the development of inhalable drugs to combat SARS-CoV-2, started in May 2020 within the frame of the international iCAIR® consortium. The iCAIR® research team, coordinated by Fraunhofer ITEM, can already report promising results for this project.

Addressing intracellular signal transduction disorders caused by viral or bacterial infections, and the therapy of inflammatory diseases are the main goals of the Frankfurt biomedicine cluster ENABLE, in which Fraunhofer ITMP is also involved. The Hessian state government will fund this project for four years with a total of eight million euros in order to prepare it successfully for the next round of the federal and state excellence strategy.

The PROXIDRUGS project was selected as part of the “Clusters4Future” competition by the German Federal Ministry of Education and Research (BMBF) and is funded with up to 15 million euros. In this project, Fraunhofer ITMP, together with seven regional partners under the leadership of the Goethe University Frankfurt am Main, is developing a novel class of active agents for the therapy of infectious, immune and neurodegenerative diseases.

The European Joint Programme on Rare Diseases (EJP-RD) will fund two newly established European consortia with participation of Fraunhofer ITMP called CureMILS and TreatKCNQ with a total of over 3.6 million euros. The aim of the research project is to develop therapies against two rare diseases in children.

In recent years, the TMP branch of Fraunhofer Institute for Molecular Biology and Applied Ecology IME, based on its extensive expertise in the field of drug re-search and development, has become an increasingly important part of Fraunhofer’s health research efforts.

This development is now reflected in the establishment of the independent Fraunhofer Institute for Translational Medicine and Pharmacology ITMP with headquarters in Frankfurt am Main and locations in Hamburg and Göttingen as of January 1, 2021.